# Amneal Pharmaceuticals, Inc. (AMRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.52B | $ 119.92M | $ -107.44M | $ 2.79B | $ 33.02M |
| 2025 | $ 3.09B | $ 73.78M | $ 242.61M | $ 2.74B | $ -70.79M |
| 2024 | $ 2.94B | $ -122.86M | $ 232.14M | $ 2.59B | $ -109.27M |
| 2023 | $ 2.59B | $ -90.82M | $ 298.85M | $ 2.75B | $ 19.78M |
| 2022 | $ 2.47B | $ -145.21M | $ -40.00M | $ 2.85B | $ 298.42M |
| 2021 | $ 2.49B | $ 12.63M | $ 230.05M | $ 2.89B | $ 360.34M |
| 2020 | $ 2.54B | $ 116.00M | $ 402.71M | $ 3.00B | $ 303.27M |
| 2019 | $ 2.10B | $ -467.14M | $ -123.56M | $ 2.77B | $ 232.01M |
| 2018 | $ 2.20B | $ -224.16M | $ 202.25M | $ 2.69B | $ 896.36M |
| 2017 | $ 1.39B | $ 226.39M | $ 161.54M | $ 1.48B | $ -385.74M |
| 2016 | $ 410.79M | $ 74.15M | $ 7.11M | $ 1.20B | $ -185.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 84.54 |
| Liabilities / Eq | 110.81 |
| Current Ratio | 2.20 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 17.40 |

## Other views

- [Metrics](https://sponda.capital/en/AMRX.md)
- [Charts](https://sponda.capital/en/AMRX/charts.md)
- [Compare](https://sponda.capital/en/AMRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.